309 related articles for article (PubMed ID: 12011252)
1. Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis.
Velickovic M; Delahunt B; McIver B; Grebe SK
Mod Pathol; 2002 May; 15(5):479-85. PubMed ID: 12011252
[TBL] [Abstract][Full Text] [Related]
2. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance.
Velickovic M; Delahunt B; Störkel S; Grebem SK
Cancer Res; 2001 Jun; 61(12):4815-9. PubMed ID: 11406557
[TBL] [Abstract][Full Text] [Related]
3. Allelic loss at 10q23.3 but lack of mutation of PTEN/MMAC1 in chromophobe renal cell carcinoma.
Sükösd F; Digon B; Fischer J; Pietsch T; Kovacs G
Cancer Genet Cytogenet; 2001 Jul; 128(2):161-3. PubMed ID: 11463457
[TBL] [Abstract][Full Text] [Related]
4. Somatic mutation and homozygous deletion of PTEN/MMAC1 gene of 10q23 in renal cell carcinoma.
Alimov A; Li C; Gizatullin R; Fredriksson V; Sundelin B; Klein G; Zabarovsky E; Bergerheim U
Anticancer Res; 1999; 19(5B):3841-6. PubMed ID: 10628321
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY
Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
[TBL] [Abstract][Full Text] [Related]
7. Infrequent genetic alterations of the tumor suppressor gene PTEN/MMAC1 in squamous cell carcinoma of the oral cavity.
Mavros A; Hahn M; Wieland I; Koy S; Koufaki ON; Strelocke K; Koch R; Haroske G; Schackert HK; Eckelt U
J Oral Pathol Med; 2002 May; 31(5):270-6. PubMed ID: 12110043
[TBL] [Abstract][Full Text] [Related]
8. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
9. Lack of deletions of the PTEN/MMAC1 and MXI1 loci in renal cell carcinoma by interphase cytogenetics.
Gesk S; Siebert R; Wacker HH; Nürnberg N; Harder L; Lehman J; Klöppel G; Grote W; Stöckle M; Schlegelberger B
Cancer Genet Cytogenet; 2000 Apr; 118(1):87-8. PubMed ID: 10766523
[No Abstract] [Full Text] [Related]
10. PTEN/MMAC1/TEP1 mutations in human primary renal-cell carcinomas and renal carcinoma cell lines.
Kondo K; Yao M; Kobayashi K; Ota S; Yoshida M; Kaneko S; Baba M; Sakai N; Kishida T; Kawakami S; Uemura H; Nagashima Y; Nakatani Y; Hosaka M
Int J Cancer; 2001 Jan; 91(2):219-24. PubMed ID: 11146448
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions.
Latini JM; Rieger-Christ KM; Wang DS; Silverman ML; Libertino JA; Summerhayes IC
J Urol; 2001 Nov; 166(5):1931-6. PubMed ID: 11586263
[TBL] [Abstract][Full Text] [Related]
12. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
Teng DH; Hu R; Lin H; Davis T; Iliev D; Frye C; Swedlund B; Hansen KL; Vinson VL; Gumpper KL; Ellis L; El-Naggar A; Frazier M; Jasser S; Langford LA; Lee J; Mills GB; Pershouse MA; Pollack RE; Tornos C; Troncoso P; Yung WK; Fujii G; Berson A; Steck PA
Cancer Res; 1997 Dec; 57(23):5221-5. PubMed ID: 9393738
[TBL] [Abstract][Full Text] [Related]
13. Somatic mutations of the PTEN/NMAC1 gene associated with frequent chromosomal loss detected using comparative genomic hybridization in endometrial cancer.
Hirai Y; Tanaka N; Furuta R; Kawaguchi T; Sakamoto M; Shirahama S; Noda T
Gynecol Oncol; 2001 Oct; 83(1):81-8. PubMed ID: 11585417
[TBL] [Abstract][Full Text] [Related]
14. Malignant papillary renal tumors with extensive clear cell change: a molecular analysis by microsatellite analysis and fluorescence in situ hybridization.
Salama ME; Worsham MJ; DePeralta-Venturina M
Arch Pathol Lab Med; 2003 Sep; 127(9):1176-81. PubMed ID: 12946227
[TBL] [Abstract][Full Text] [Related]
15. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas.
Liu W; James CD; Frederick L; Alderete BE; Jenkins RB
Cancer Res; 1997 Dec; 57(23):5254-7. PubMed ID: 9393744
[TBL] [Abstract][Full Text] [Related]
16. PTEN / MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas.
Fujiwara Y; Hoon DS; Yamada T; Umeshita K; Gotoh M; Sakon M; Nishisho I; Monden M
Jpn J Cancer Res; 2000 Mar; 91(3):287-92. PubMed ID: 10760687
[TBL] [Abstract][Full Text] [Related]
17. Detection of new PTEN/MMAC1 mutations in head and neck squamous cell carcinomas with loss of chromosome 10.
Poetsch M; Lorenz G; Kleist B
Cancer Genet Cytogenet; 2002 Jan; 132(1):20-4. PubMed ID: 11801303
[TBL] [Abstract][Full Text] [Related]
18. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas.
Wang JY; Huang TJ; Chen FM; Hsieh MC; Lin SR; Hou MF; Hsieh JS
Virchows Arch; 2003 May; 442(5):437-43. PubMed ID: 12695913
[TBL] [Abstract][Full Text] [Related]
19. Analysis of PTEN/MMAC1 alterations in aerodigestive tract tumors.
Okami K; Wu L; Riggins G; Cairns P; Goggins M; Evron E; Halachmi N; Ahrendt SA; Reed AL; Hilgers W; Kern SE; Koch WM; Sidransky D; Jen J
Cancer Res; 1998 Feb; 58(3):509-11. PubMed ID: 9458098
[TBL] [Abstract][Full Text] [Related]
20. [Correlation between the PTEN/MMAC1/TEP1 expression and cell proliferation and apoptosis in human renal cell carcinoma (RCC)].
Li JY; Cao RF; Wang H; Xie QX; Wang GX; Xiong LS; Miao YR
Ai Zheng; 2003 Jun; 22(6):607-11. PubMed ID: 12948410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]